Purine analogues kill resting lymphocytes by p53-dependent and - independent mechanisms

British Journal of Haematology

Volumn 105, Issue 4, 1999, Pages 986-988

  Pettitt, A R ^a,c   Clarke, A R ^b   Cawley, J C ^a   Griffiths, S D ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Chlorodeoxyadenosine; Deoxycoformycin; Fludarabine; p53

Indexed keywords

CHLORODEOXYADENOSINE; FLUDARABINE; PENTOSTATIN; PROTEIN P53; PURINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; LYMPHOCYTOTOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL DEATH; CLADRIBINE; COFORMYCIN; DEXAMETHASONE; DRUG RESISTANCE; ETOPOSIDE; GENES, P53; LYMPHOCYTES; MICE; MICE, KNOCKOUT; SPLEEN; VIDARABINE;

EID: 0033028601     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01448.x     Document Type: Article

References (12)

1. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L. & Wyllie, A.H. (1993) Thymocyte apoptosis induced by p53-dependent and -independent pathways. Nature, 362, 849-852.
2. Dohner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P.R., Poustka, A., Hunstein, W. & Lichter, P. (1995) p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 1580-1589.
3. Gartenhaus, R.B., Wang, P., Hoffman, M., Janson, D. & Rai, K.R. (1996) The induction of p53 and WAP1/CIP1 in chronic lymphocytic leukemia cells treated with 2-chlorodeoxyadenosine. Journal of Molecular Medicine, 74, 143-147.
4. Johnston, J.B., Daeninck, P., Verburg, L., Lee, K., Williams, G., Israels, L.G., Mowat, M.R. & Begleiter, A. (]997) p53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Leukemia and Lymphoma, 26, 435-449.
5. Kawasaki, H., Carrera, C.J., Piro, L.D., Saven, A., Kipps, T.J. & Carson, D.A. (1993) Relationship of deoxycytidine kinase and cytoplasmic 5′-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. Blood, 81, 597-601.
6. Ko, L.J. & Prives, C. (1996) p53: puzzle and paradigm. Genes and Development, 10, 1054-1072.
7. Lens, D., Dyer, M.J., Garcia-Marco, J.M., de-Schouwer, P.J., Hamoudi, R.A., Jones, D., Farahat, N., Matutes, E. & Catovsky, D. (1997) p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. British Journal of Haematology. 99, 848-857.
8. Ormerod, M.G. (1998) The study of apoptotic cells by flow cytometry. Leukemia, 12, 1013-1025.
9. Szondy, Z. (1995) The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine. Biochemical Journal, 311, 585-588.
10. Tallman, M.S. & Hakimian, D. (1995) Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood, 86, 2463-2474.
11. Thomas, A., El Rouby, S., Reed, J., Krajewski, S., Silber, R., Potmesil, M. & Newcombe, E. (1996) Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene, 12, 1055-1062.
12. Wattel, E., Preudhomme, C., Hecquet, B., Vanrumbeke, M., Quesnel, B., Dervite, I., Morel, P. & Fenaux, P. (1994) p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood, 84, 3148-3157.